French lawmakers may mandate conflict of interest disclosures
At a time when our own government has stepped back from requiring true transparency about conflicts of interest in medicine, French lawmakers seem to be heading in a much bolder direction. According...
View ArticleDrug and medical device industry launches push to weaken FDA oversight
With the Obama administration hobbled by a Republican-led Congress, the pharmaceutical and medical device industry seems to have launched a concerted push to roll back regulatory initiatives designed...
View ArticleDeceptive drug research practices explain why over-medicating of children...
A new report from the U.S. Government Accountability office confirms something that Rose Firestein, the eponymous prosecutor in the title of Side Effects: A Prosecutor, a Whistleblower and Bestselling...
View ArticleWhen it comes to scientific misconduct, should there be a statute of...
I was hesitant to weigh in at first when I learned that Brown University’s School of Medicine had decided not to pressure a psychiatric journal to retract the seriously flawed Paxil study that I wrote...
View ArticleHow drug companies continue to hide the true story of Tamiflu and other drugs...
I’ve been reading Dr. David Healy’s new book, Pharmageddon, and while some of it may seem like old news, I was struck by his fresh analysis of how the pharmaceutical industry has turned the original...
View ArticleIs the FDA violating its own mandate to approve safe drugs?
Is the Food and Drug Administration violating its own mandate to approve safe drugs? That was the question that Donald Light, co-author of The Risk for Prescription Drugs and a long-time medical...
View ArticleInstitute of Medicine report concludes that the FDA is not doing adequate job...
Two weeks ago, I headlined my blog with this question: Is the FDA violating its own mandate to approve safe drugs? Four days later, the national Institute of Medicine (IOM) released a 233-page report...
View ArticleFast-moving bill in Congress would weaken FDA oversight of new drugs and devices
Congress is moving quickly to pass a bill that would authorize higher industry fees for the FDA in exchange for speeding up the approval of some drugs and medical devices and eliminating restrictions...
View ArticlePlot twists in Soderbergh’s new movie Side Effects strain belief
I went to see Steven Soderbergh’s new film, Side Effects, with anticipation and dread. The movie, after all, carries the same name as my 2008 book, Side Effects and from what I could tell of the...
View ArticleA review of two new books that attack the DSM-5, psychiatry’s “bible”
I reviewed two books now circulating about the DSM and the current controversy over the DSM-5 for The American Scholar — see review here. The two books are The Book of Woe: The DSM and the Unmaking of...
View Article
More Pages to Explore .....